Matching Treatment to Need: Using GLP-1 Agonists Across the Clinical Spectrum of Type 2 Diabetes Sponsored by Novo-Nordisk

Sunday, October 14, 2012, 11:30 a.m. - 1:30 p.m.
San Diego Convention Center
Location: Convention Center, Ballroom 6E, Level 2
Continuing Education Credits: 0.15 (1.5 Contact Hours)
ACPE #: 207-000-12-225-L01-P

The management of type 2 diabetes, and in particular blood glucose, can be complex and burdensome. A large proportion of patients are not achieving glycemic goals and many are frustrated with the limitations of currently available agents with regard to weight gain, hypoglycemia, and tolerability issues. Patient adherence to diabetes regimens is a major barrier to the ideal management of diabetes. Ongoing patient education and feedback is critical to successful self-management for patients with type 2 diabetes -- a role that can be successfully fulfilled by pharmacists. This application-based, interactive continuing education program will explore the clinical differences between the incretin-based therapies and discuss strategies on how to effectively communicate these differences to a patient with type 2 diabetes that will improve their ability to self-manage their disease and achieve improved outcomes.

Pharmacist Learning Objectives:

  1. Differentiate GLP-1 receptor agonists from DPP-4 inhibitors based on clinical effects such as glucose-lowering, weight, cardiometabolic, routes of administration, and adverse-effect profile.
  2. Differentiate short- and long-acting GLP-1 receptor agonists from each other with regard to glucose-lowering, adverse effect profiles, and dosing.
  3. List common challenges that may interfere with patients' ability to implement and adhere to diabetes self-care plans and medication regimens.
  4. Outline key communication strategies that pharmacists can use to ensure productive conversations with patients.
  5. Practice medication therapy management principles for patients receiving prescriptions for incretin-based therapies.

Speakers: Jerry Meece, RPh, FACA, CDM, CDE, Director of Clinical Services, Plaza Pharmacy and Wellness Center, Gainesville, Texas; David L. Joffe, BSPharm, CDE, FACA, Assistant Clinical Professor, University of Florida College of Pharmacy, St. Petersburg, Florida; Sandra Bollinger, PharmD, FASCP, CGP, CDE, CPT, CFts, President, Health Priorities, Inc., Sikeston, Missouri

Activity Type: Application-based
Audience: Pharmacists

Ask Your Family Pharmacist TM